Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
May 1994

Documentation for Immediately Dangerous To Life or Health Concentrations (IDLHs)

Triorthocresyl phosphate

CAS number: 78–30–8

NIOSH REL: 0.1 mg/m3 TWA [skin]

Current OSHA PEL: 0.1 mg/m3 TWA

1989 OSHA PEL: 0.1 mg/m3 TWA [skin]

1993-1994 ACGIH TLV: 0.1 mg/m3 TWA [skin]

Description of substance: Colorless to pale-yellow, odorless liquid or solid (below 52°F).

LEL: . . Unknown

Original (SCP) IDLH: 40 mg/m3

Basis for original (SCP) IDLH: No data on acute inhalation toxicity are available on which to base an IDLH for triorthocresyl phosphate. The chosen IDLH has been estimated from oral toxicity data cited by ACGIH [1971]. ACGIH [1971] reported that serious paralysis has been produced in man by an oral dose of the order of 6 to 7 mg/kg [Patty 1963].

Short-term exposure guidelines: None developed


Lethal dose data:






Adjusted LDDerived value
MouseBleiberg &Johnson 1965 oral900-----6,300 mg/m3630 mg/m3
RabbitGross & Grosse 1932 oral-----100700 mg/m370 mg/m3
RatVeronesi et al. 1984 oral1,160 -----8,120 mg/m3 812 mg/m3

Human data: It has been reported that serious paralysis has been produced by an oral dose of about 6.6 mg/kg [Deichmann and Gerarde 1969] and that the probable lethal dose is greater than 28 mg/kg [Patty 1963]. [Note: Oral doses of 6.5 or 28 mg/kg are equivalent to a 70-kg worker being exposed to about 300 or 1,300 mg/m3, respectively, for 30 minutes, assuming a breathing rate of 50 liters per minute and 100% absorption.]


Revised IDLH: 40 mg/m3 [Unchanged]

Basis for revised IDLH: No inhalation toxicity data are available on which to base an IDLH for triorthocresyl phosphate. However, based on acute oral toxicity data in humans [Deichmann and Gerarde 1969; Patty 1963], the original IDLH for triorthocresyl phosphate (40 mg/m3) is not being revised at this time.


1. ACGIH [1971]. Triorthocresyl phosphate. In: Documentation of the threshold limit values for substances in workroom air. 3rd ed. Cincinnati, OH: American Conference of Governmental Industrial Hygienists, pp. 271-272.

2. Bleiberg MJ, Johnson H [1965]. Effects of certain metabolically active drugs and oximes on tri-o-cresyl phosphate toxicity. Toxicol Appl Pharmacol 7:227-235.

3. Deichmann WB, Gerarde HW [1969]. Tricresyl phosphates. In: Toxicology of drugs and chemicals. New York, NY: Academic Press, Inc., Inc., p. 604.

4. Gross E, Grosse A [1932]. A contribution on the toxicology of ortho-tri-cresyl-phosphates. Arch Exp Pathol Pharmakol 168:473-514 (in German).

5. Patty FA, ed. [1963]. Industrial hygiene and toxicology. 2nd rev. ed. Vol. II. Toxicology. New York, NY: Interscience Publishers, Inc., p. 1920.

6. Veronesi B, Newland D, Inman A [1984]. The effect of metabolic interference on rodent-sensitivity to tri-ortho-cresyl phosphate (TOCP). Toxicologist 4:55 [Abstract].

Contact Us: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO